Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Advanced Oncotherapy PLC Announces Issue Of Equity


Wednesday, 10 Jul 2013 02:00am EDT 

Advanced Oncotherapy PLC announced that it has conditionally placed 16,666,667 new ordinary shares of the Company at a subscription price of 3 pence per new ordinary share to raise GBP0.5 million before expenses. The subscription price represents an 85% premium to the closing mid-market share price on July 9, 2013. The shares have been placed with two investors, one in Switzerland and one in the United Kingdom, and the money will be used to pay down debt. Application has been made for the new ordinary shares to be admitted to trading on AIM and it is expected that trading will commence on or about July 15, 2013. The new ordinary shares will rank pari passu in all respects with the existing ordinary shares of the Company. 

Company Quote

3.9
0.0 +0.00%
10:52am EST